Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

340.00p
   
  • Change Today:
    -17.50p
  • 52 Week High: 492.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 46.80m
  • Volume: 102,304
  • Market Cap: £159.12m

Faron Pharmaceuticals hits bump in road for Traumakine manufacturing

By Josh White

Date: Wednesday 02 Oct 2019

LONDON (ShareCast) - (Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that, further to its update in its interim results in relation to the active pharmaceutical ingredient (API) manufacturing process for 'Traumakine', Rentschler Biopharma has sent Faron a letter in which it terminated the agreement concerning the API manufacturing.
The AIM-traded firm said it understood that related to the fact that "significant" upgrading of the API manufacturing process would be required prior to MAA/BLA approval for Traumakine.

"The company is exploring various options for future API manufacturing," the board said in its statement.

"This termination has no impact on the currently on-going clinical advice process with FDA/EMA, which focuses on the structure of the next Traumakine clinical study."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 340.00p
Change Today -17.50p
% Change -4.90 %
52 Week High 492.00
52 Week Low 80.50
Volume 102,304
Shares Issued 46.80m
Market Cap £159.12m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average89.29% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 03-Jun-2020

Time Volume / Share Price
16:35 6,637 @ 340.00p
15:59 100 @ 341.00p
14:15 10,001 @ 334.09p
14:09 10,000 @ 343.00p
14:54 1,096 @ 341.00p

FARN Key Personnel

CEO Markku Jalkanen
CFO Yrjö E K Wichmann

Top of Page